U.S. RESEARCH ROUNDUP- Cerevel Therapeutics, Cytokinetics, Karuna Therapeutics

Cerevel Therapeutics Holdings

28/12/2023 06:42

Dec 28 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Cerevel Therapeutics, Cytokinetics and
Karuna Therapeutics on Thursday. 
    
  HIGHLIGHTS        
        
  
                 * Cerevel Therapeutics Holdings Inc  CERE.O : JP Morgan raises PT to $45 from $25
 
                 * Cytokinetics Inc  CYTK.O : Needham raises target price to $108 from $60
 
                 * Karuna Therapeutics Inc  KRTX.O : JP Morgan cuts to neutral from overweight
 
                 * Microsoft  MSFT.O : Wedbush raises target price to $450 from $425
 
                 * Rayzebio Inc  RYZB.O : JP Morgan cuts to neutral from overweight
 
                
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order.         
    
                 * Cerevel Therapeutics Holdings Inc  CERE.O : JP Morgan raises PT to $45 from $25
 
                 * Cytokinetics Inc  CYTK.O : H.C. Wainwright raises target price to $94 from $58
 
                 * Cytokinetics Inc  CYTK.O : Leerink Partners raises target price to $95 from $58
 
                 * Cytokinetics Inc  CYTK.O : Needham raises target price to $108 from $60
 
                 * Cytokinetics Inc  CYTK.O : Truist Securities raises target price to $86 from $60
 
                 * Karuna Therapeutics Inc  KRTX.O : JP Morgan cuts to neutral from overweight
 
                 * Karuna Therapeutics Inc  KRTX.O : JP Morgan raises target price to $330 from $217
 
                 * Microsoft  MSFT.O : Wedbush raises target price to $450 from $425
 
                 * Neogenomics Inc  NEO.O : Leerink Partners cuts target price to $26 from $30
 
                 * Rayzebio Inc  RYZB.O : JP Morgan cuts to neutral from overweight
 
                 * Rayzebio Inc  RYZB.O : JP Morgan raises target price to $62 from $30
 
                 * Rayzebio Inc  RYZB.O : Truist Securities raises target price to $62 from $29
 
                 * Safehold Inc  SAFE.N : JP Morgan raises target price to $23 from $17
 
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))